date,title,source
Nov-09-18,NASH clinical trial presentation and continued revenue growth,GlobeNewswire
Nov-19-18,"Immuron Appoints Gary S. Jacob, Ph.D., Experienced US Based Biotechnology Executive, as CEO",GlobeNewswire
Nov-26-18,One Thing To Remember About The Immuron Limited (ASX:IMC) Share Price,Simply Wall St.
Jan-08-19,Immuron Receives $1.19M R&D Tax Concession Refund,GlobeNewswire
Feb-11-19,What You Must Know About Immuron Limiteds (ASX:IMC) Financial Strength,Simply Wall St.
